Vaccinated and Convalescent Donor–Derived Severe Acute Respiratory Syndrome Coronavirus 2–Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an urgent need for the development of effective therapies for coronavirus disease 2019 (COVID-19). METHODS: We first tested SARS-CoV-2–specific T-cell (CοV-2-ST) immunity and expansion in unexposed donors, CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Papayanni, Penelope-Georgia, Chasiotis, Dimitrios, Koukoulias, Kiriakos, Georgakopoulou, Aphrodite, Iatrou, Anastasia, Gavriilaki, Eleni, Giannaki, Chrysavgi, Bitzani, Militsa, Geka, Eleni, Tasioudis, Polychronis, Chloros, Diamantis, Fylaktou, Asimina, Kioumis, Ioannis, Triantafyllidou, Maria, Dimou-Besikli, Sotiria, Karavalakis, Georgios, Boutou, Afroditi K, Siotou, Eleni, Anagnostopoulos, Achilles, Papadopoulou, Anastasia, Yannaki, Evangelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135332/
https://www.ncbi.nlm.nih.gov/pubmed/33905481
http://dx.doi.org/10.1093/cid/ciab371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135332/
https://www.ncbi.nlm.nih.gov/pubmed/33905481
http://dx.doi.org/10.1093/cid/ciab371

Ejemplares similares